Inactive Instrument

Highlights KARA THER

Equities

KRTX

US48576A1007

Highlights

Unlock all the news: Be the first to know and act before the market!

Bristol-Myers Squibb Completes Karuna Therapeutics Acquisition	Mar. 18	MT
PureTech Health: Bristol Myers Squibb Wraps Up $14 Billion Acquisition of Karuna	Mar. 18	MT
Karuna Therapeutics, Inc. and Miramar Merger Sub Inc. Announce Management Changes	Mar. 18	CI
Bristol Myers: completes acquisition of Karuna Therapeutics	Mar. 18	CF
Bristol-Myers Squibb Company completed the acquisition of Karuna Therapeutics, Inc. from Capital International Investors, FMR LLC, The Vanguard Group, Inc., T. Rowe Price Group, Inc. and others.	Mar. 17	CI
Karuna Therapeutics Q4 Loss Widens	Feb. 22	MT
Karuna Therapeutics, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	Feb. 22	CI
Karuna Therapeutics, Inc. Reports Earnings Results for the Fourth Quarter Ended December 31, 2023	Feb. 22	CI
Bristol Myers Squibb Reportedly Eyeing $13 Billion from Bond Sale Launched Wednesday	Feb. 14	MT
Bristol Myers posts better-than-expected 4th-quarter results	Feb. 02	RE
North American Morning Briefing : Cautious Start -2-	Jan. 29	DJ
Bristol Myers expects to launch 16 new products through 2030 - CEO	Jan. 08	RE
North American Morning Briefing : S&P 500 Hovers Near Record as Interest Rate Optimism Holds Sway	Dec. 27	DJ
Bristol-Myers Agrees Deal to Buy RayzeBio for About $4.1 Billion	Dec. 26	MT
Bristol Myers Squibb to Buy RayzeBio for $4.1 Billion	Dec. 26	DJ
Health Care Climbs Amid Deal Activity -- Health Care Roundup	Dec. 22	DJ
Wall Street turns negative ahead of long holiday weekend	Dec. 22	RE
Dpa-AFX Overview: COMPANIES from 22.12.2023 - 15:15	Dec. 22	DP
Bristol Myers: agreement to acquire Karuna Therapeutics	Dec. 22	CF
Bristol Myers Squibb To Buy Karuna Therapeutics For $14 Bln	Dec. 22	RE

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Highlights KARA THER

Equities

KRTX

US48576A1007

Highlights

Filters